Radiofrequency ablation (RFA) for back pain is a minimally invasive outpatient procedure that uses heat generated by radio waves to interrupt pain signals from targeted spinal nerves — most commonly the medial branch nerves supplying facet joints. Patients with confirmed facet-mediated pain who respond to diagnostic nerve blocks are the primary candidates. Effects typically last 6–24 months, and the procedure does not repair underlying disc or tissue damage.

Back pain is the leading cause of disability worldwide, and 80% of people experience it at some point in their lifetime. For patients whose pain originates from the facet joints rather than a damaged disc, RFA delivers meaningful relief without surgery. Understanding exactly what RFA is — and what it cannot address — helps patients evaluate it alongside the full spectrum of non-surgical spine treatment options.

Nearly 1 in 5 patients told they need spine surgery choose not to have it, and back surgery carries roughly a 40% failure rate. RFA occupies a defined middle ground: more targeted than general injections, less invasive than surgery, and evidence-backed for a specific subset of spine pain. For patients whose pain has a disc-related origin rather than a facet origin, a different treatment pathway applies — one worth exploring through a structured decision framework.

What Exactly Is Radiofrequency Ablation?

Radiofrequency ablation — also called radiofrequency neurotomy or medial branch neurotomy — is a procedure in which a specialized needle-probe delivers radiofrequency electrical current to a targeted nerve, generating localized heat that creates a small lesion disrupting pain signal transmission. For the spine, the target is almost always the medial branch nerve: the sensory nerve that carries pain signals from the facet joint to the brain.

The term “ablation” means the destruction or removal of tissue. The nerve is not permanently severed; it regenerates over time, which is why RFA produces temporary rather than permanent pain relief.

Also known as:

Radiofrequency neurotomy, medial branch neurotomy, RFA, RF ablation

Target structure:

Medial branch nerves of the posterior primary rami (facet joint innervation)

Duration of effect:

6–24 months; repeatable when the nerve regenerates

Structural repair:

None — RFA addresses the pain signal only, not underlying tissue damage

How Does the Radiofrequency Ablation Procedure Work?

The procedure follows a defined sequence guided by continuous fluoroscopic (X-ray) imaging throughout.

1. Patient positioning. The patient lies face-down on a fluoroscopy table. Continuous imaging guides every step of needle placement.
2. Local anesthesia. The target area is numbed. Patients are typically awake or lightly sedated — general anesthesia is not required.
3. Needle placement. A specially insulated introducer needle is advanced to a position parallel to the target medial branch nerve. Precise positioning is critical: the active tip must lie along the nerve’s course, not simply adjacent to the joint.
4. Sensory and motor testing. Before ablating, the physician stimulates at low frequency (50 Hz) to confirm proximity to sensory fibers, then at higher frequency (2 Hz) to confirm no proximity to motor roots.
5. Thermal lesioning. Once position is confirmed, radiofrequency energy heats the probe tip to approximately 80°C for 60–90 seconds, coagulating the nerve tissue.
6. Recovery. Patients go home the same day. Soreness at the needle sites is common for 1–2 weeks; full pain relief develops gradually as the nerve’s ability to transmit pain signals diminishes.

A single-level treatment addresses two to three medial branch nerves per side. Bilateral or multi-level treatments extend procedure time but follow the same protocol.

Who Is RFA Designed to Help?

RFA is specifically designed for patients whose chronic back or neck pain is facet-mediated — meaning the facet joints, not a damaged or torn disc, are the dominant pain generator. A clinical evaluation is the only way to know for certain whether a patient’s pain has a facet origin.

30% of U.S. adults have experienced recent low back pain. A substantial proportion of chronic low back pain — estimates range from 15% to 40% in specialist settings — is facet-mediated. Facet joints are the small paired joints at each vertebral level that guide movement and limit excessive rotation. Like any synovial joint, they can develop arthritis, inflammation, and chronic pain.

For patients with facet-mediated pain, the standard treatment sequence typically looks like this:

1. Conservative care (physical therapy, NSAIDs, activity modification)
2. Facet joint injections (corticosteroid — diagnostic and therapeutic)
3. Medial branch blocks (diagnostic — confirms the nerve as the pain source)
4. Radiofrequency ablation — therapeutic, reserved for patients who demonstrate meaningful relief from at least two diagnostic medial branch blocks

That prerequisite — confirmed response to diagnostic blocks — substantially improves outcomes and ensures the correct nerve is targeted before proceeding.

What Are the Limits of RFA?

RFA addresses pain signal transmission only. It does not repair torn disc tissue, seal annular tears, restore disc height, or address disc-related nerve compression. For patients whose pain originates from disc pathology — herniated discs, annular tears, or degenerative disc changes — RFA is not designed to address the underlying source.

Key limitations to understand:

• Temporary effect: Nerves regenerate; most patients experience 6–24 months of relief before the procedure may need to be repeated.
• Narrow candidacy: Patients must have confirmed facet-mediated pain with a documented positive response to diagnostic blocks. Mixed-origin pain (facet plus disc) produces less predictable outcomes.
• No tissue healing: RFA does not address the structural cause of pain — only the signal pathway.
• Procedural soreness: Post-procedure soreness at needle sites typically lasts 1–2 weeks.

For patients whose pain has a disc origin — including annular tears and disc herniation — a different category of treatment is relevant. The decision framework for evaluating spine treatment options covers how to distinguish facet-mediated from disc-mediated pain and what that distinction means for treatment planning.

How Does RFA Compare to Other Non-Surgical Options?

RFA fits a specific clinical niche. Comparing it to other approaches helps clarify when it is — and is not — the right tool.

For a detailed evidence comparison, see how to compare non-surgical spine treatments. For patients considering whether disc-directed treatment is appropriate, the fibrin disc treatment vs. spinal fusion FAQ covers the key distinctions in plain English.

Among tracked outcomes for the intra-annular fibrin injection — across more than 7,000 procedures with long-term follow-up — the reported success rate is 83%; individual outcomes vary. That data point is relevant context when patients are comparing treatment pathways, though the right comparison starts with correctly identifying the pain source.

On the epidural steroid side, an AAFP systematic review found epidural steroid injections are “not effective” for chronic low back pain. RFA is more targeted than epidural steroids for facet-specific pain, but neither addresses disc-origin pathology. For more on that comparison, see lumbar epidural steroid injection vs. regenerative biologics.

What Should Patients Know Before Pursuing RFA?

A clinical evaluation — including diagnostic medial branch blocks — is the necessary prerequisite before RFA is appropriate. Patients who proceed without confirmed diagnostic block response have substantially lower success rates.

Key questions to discuss with a spine specialist before RFA:

• Has my pain been confirmed as facet-mediated through diagnostic blocks?
• Are there disc-related findings on my imaging that could be contributing to the pain?
• What happens if RFA provides only partial or temporary relief?
• Is my pain pattern consistent with facet joint involvement, or could it have a mixed or disc origin?

For patients who have tried RFA and continue to experience significant pain, a disc-origin evaluation is the logical next step. The FAQ on back pain surgery vs. non-surgical options addresses what the evidence supports when conservative and interventional approaches have not resolved the pain.

Frequently Asked Questions About Radiofrequency Ablation for Back Pain

How long does radiofrequency ablation last?

RFA effects typically last 6–24 months. The medial branch nerve regenerates over time, and the procedure can be repeated when pain returns.

Duration varies based on the level treated, the accuracy of initial nerve targeting, and individual patient factors. Some patients report relief extending beyond 24 months; others experience shorter intervals. A clinical evaluation can help set realistic expectations before the procedure.

Is radiofrequency ablation effective for all types of back pain?

RFA is effective specifically for facet-mediated back pain confirmed by diagnostic nerve blocks. It is not designed to address disc-origin pain, herniated discs, or annular tears.

Patients with mixed-origin pain — where both facet and disc pathology are present — often experience less predictable outcomes from RFA alone. Accurate diagnosis of the pain source is the most important factor in predicting whether RFA will be effective.

What is the difference between RFA and an epidural steroid injection?

RFA targets the medial branch nerve to interrupt the pain signal from a facet joint. An epidural steroid injection delivers anti-inflammatory medication to the epidural space and is intended to reduce inflammation around nerve roots.

The two procedures target different structures and are appropriate for different diagnoses. An AAFP systematic review found epidural steroid injections are “not effective” for chronic low back pain. RFA has stronger evidence for facet-specific pain but no evidence base for disc-related pain.

Can RFA be repeated if pain returns?

Yes. Because the medial branch nerve regenerates, RFA can be repeated when the nerve recovers and pain returns. Repeat procedures follow the same diagnostic confirmation protocol as the initial treatment.

What is the difference between RFA and intra-annular fibrin injection?

RFA targets the medial branch nerve that transmits facet joint pain signals. Intra-annular fibrin injection uses an FDA-approved fibrin sealant delivered to the inside of a damaged disc to seal annular tears — designed to address disc-origin pain at its structural source.

The two procedures treat different pain generators. RFA is appropriate for confirmed facet-mediated pain. The fibrin procedure is designed for patients with disc-origin pain — including annular tears and disc herniation — who have not found lasting relief from conservative care. A clinical evaluation is the only way to determine which category applies to a given patient’s pain. For a detailed comparison, see PRP vs. intra-annular fibrin injection.

Is RFA covered by insurance or VA benefits?

RFA is covered by many insurance plans when diagnostic criteria — including positive response to medial branch blocks — are documented. For veterans, coverage depends on VA eligibility and, in some cases, Mission Act criteria. Under the Mission Act, certain procedures may be covered VA benefits when the VA cannot provide timely or appropriate care; coverage is determined case-by-case by the VA. A clinical evaluation is the starting point for any coverage determination.

This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.